ADVENTRX Pharmaceuticals Inc. Reports Second Quarter 2007 Financial Results
SAN DIEGO, Aug. 2 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (Amex: ANX - News) a biopharmaceutical research and development company focused on commercializing proprietary product candidates for the treatment of cancer and infectious diseases, today announced financial results for the three-month and six-month periods ended June 30, 2007.